JOURNEY MEDICAL CORP (DERM:NASDAQ)
$6.91 -0.09 (-1.2857%)
Analysed JOURNEY MEDICAL CORP (DERM:NASDAQ) News Sources
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
13-05-2026
yahoo.com
Journey Medical Corporation (DERM) Reports Q1 Loss, Beats Revenue Estimates
13-05-2026
yahoo.com
Transcript: Journey Medical Q1 2026 Earnings Conference Call
13-05-2026
yahoo.com
Journey Medical (DERM) Q1 2026 Earnings Transcript
13-05-2026
fool.com
Here's What Key Metrics Tell Us About Journey Medical (DERM) Q1 Earnings
13-05-2026
yahoo.com
Journey Medical Corp (DERM) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...
14-05-2026
yahoo.com
Journey Medical Corporation Q1 2026 Earnings Call Summary
15-05-2026
moby.co
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
19-05-2026
yahoo.com
How The Journey Medical (DERM) Investment Narrative Is Evolving With An Unchanged Valuation Target
03-06-2026
yahoo.com
Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes
25-06-2026
yahoo.com
What is the current price of JOURNEY MEDICAL CORP (DERM:NASDAQ)?
The current price of JOURNEY MEDICAL CORP (DERM:NASDAQ) is $6.91.
JOURNEY MEDICAL CORP (DERM:NASDAQ) absolute price change since previous trading day?
The absolute price change of JOURNEY MEDICAL CORP (DERM:NASDAQ) since the previous trading day is $-0.09.
JOURNEY MEDICAL CORP (DERM:NASDAQ) percentage price change since previous trading day?
The percentage price change of JOURNEY MEDICAL CORP (DERM:NASDAQ) since the previous trading day is -1.2857%.
What is the most recent average sentiment score for JOURNEY MEDICAL CORP (DERM:NASDAQ)?
The most recent average sentiment score for JOURNEY MEDICAL CORP (DERM:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for JOURNEY MEDICAL CORP (DERM:NASDAQ)?
The most recent sentiment for JOURNEY MEDICAL CORP (DERM:NASDAQ) is .
SEC-8K** Filing Available For JOURNEY MEDICAL CORP (DERM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.